Table 2 Demographic Summary of TLCN HCC cohort

Age

66.3 ± 8.4 (59.3–72.0)

66.0 ± 14.9 (61.0–76.0)

Gender

Male:32, Female:8

Male:22, Female:10

Presence of cirrhosis

45.0%

21.9%

Tumor size (cm)

4.5 ± 2.3 (3.0–5.9)

8.0 ± 5.1 (3.5–11.8)

Positive frequency^a

(Tumor, Non-Tumor)

(Tumor, Non-Tumor)

 IL-17A

80.0%, 75.0%

87.5%, 87.5%

 IL-17F

47.5%, 15.0%

40.6%, 18.8%